Β-Thalassemias | NEJM
Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis
Sirolimus for Treatment of β-Thalassemia: From Pre-Clinical Studies to the Design of Clinical Trials
Pathophysiology and treatment of patients with... | F1000Research
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
Frontiers | New Insights Into Pathophysiology of β-Thalassemia
Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment | Gene Therapy
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
IJMS | Free Full-Text | Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
Safety and efficacy of thalidomide in patients with transfusion-dependent β- thalassemia: a randomized clinical trial | Signal Transduction and Targeted Therapy
A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies? - ScienceDirect
β-Thalassemia | Genetics in Medicine
An urgent need for improving thalassemia care due to the wide gap in current real-life practice and clinical practice guidelines | Scientific Reports
Current and future alternative therapies for beta-thalassemia major - ScienceDirect
Full article: Revisiting beta thalassemia intermedia: past, present, and future prospects
2021 update on clinical trials in β‐thalassemia - Musallam - 2021 - American Journal of Hematology - Wiley Online Library
Cureus | Thalassemia: A Review of the Challenges to the Families and Caregivers
Novel genetic therapeutic approaches for modulating the severity of β‑ thalassemia (Review)
Non-transfusion-dependent thalassemias | Haematologica
Β-Thalassemias | NEJM
Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine | Scientific Reports
Novel genetic therapeutic approaches for modulating the severity of β‑ thalassemia (Review)
JCM | Free Full-Text | Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia?
Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation | SpringerLink
